Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H.P. Acthar Gel in non-infectious retinal vasculitis
NCT03066869Phase 4Unknown
- Sponsor
- Ocular Immunology and Uveitis Foundation
- Start
- Mar 2017
- Primary completion
- Feb 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of repository corticotropin injection in retinal vasculitis (RV), sponsored by Ocular Immunology and Uveitis Foundation. Status: unknown.
02
Drugs
repository corticotropin injection
03
Conditions
retinal vasculitis (RV)
Beyond the preview
Go deeper on NCT03066869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03066869.